Anti-tumor activity is enhanced by the loss of TIM-3 on dendrites because it inhibits the dendritic cells from performing regulatory functions while facilitating the functions of CD8+ effector and stem like T-cells 23. This evidence concerns the gene HAVCR2 and neoplasm.